News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genisphere Adapts 3DNA® Dendrimer Technology to Lateral Flow Point-of-Care Assays



7/17/2012 10:29:38 AM

HATFIELD, Pa.--(BUSINESS WIRE)--Genisphere has adapted its pioneering 3DNA Dendrimer Signal Amplification technology for Lateral Flow (LF) Point-of-Care (POC) assays, providing improved sensitivity and enabling a broad new array of POC tests. LF assays represent a unique and growing class of POC tests designed to rapidly diagnose patients within clinically actionable timeframes.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES